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ABSTRACT 
 The objective of this study was to determine whether feeding Amaferm, a fermentation 
extract of Aspergillus oryzae, improved the health and performance of Holstein bull calves from 
birth to weaning. Calves were randomly assigned to a slaughter age (4 wk (n = 16) or 8 wk (n = 
36)) and treatment (control (CON; n = 27) or Amaferm (AMF; n = 25)). AMF calves were fed 2 
g of AMF daily, delivered in milk replacer for the first 4 wk of life and top-dressed on starter 
thereafter. Calves were fed milk replacer twice daily and were weaned upon consuming 0.91 kg 
of grain daily or on d 45 of the study. Calves had ad libitum access to grain and water. Milk 
replacer and starter intakes were recorded daily. Body weight was recorded weekly. Fecal scores 
were assigned twice daily. Upon slaughter, jejunal lymph nodes were collected for flow 
cytometric analysis of CD4 and CD8 cell populations. Body weights and medical costs were 
consistent between treatments. Calves fed AMF had greater frequency of scours than calves not 
fed AMF. CD4 cells composed a higher percentage of observed cells in AMF calves, while there 
was no difference in CD8 cell percentages between treatments. In conclusion, calves fed AMF 
scoured more frequently, but a lesser percentage of AMF calves were treated for respiratory 
ailments leading to no effect on treatment costs. Interestingly, CD4 cell population was greater in 
AMF calves, which warrants further research. 
INTRODUCTION, JUSTIFICATION, AND HYPOTHESIS 
The period from birth to weaning is a stressful time for dairy calves. The most prevalent 
causes of death from during this period are scours and respiratory problems (USDA NAHMS 
2011). Calf mortality and treatment costs represent an enormous economic loss to the dairy 
industry, estimated to be greater than $250 million annually (Davis and Drackley, 1998). 
Amaferm (AMF) (Biozyme, Inc.; St. Joseph, MO), a fermentation extract of Aspergillus 
oryzae, is a direct fed microbial with probiotic and prebiotic properties. AMF has been studied in 
both ruminants and nonruminants with favorable outcomes in fiber digestibility (Chang et al., 
1999) and suspected benefits in gut health (http://www.biozymeinc.com/research/pigs.html), 
respectively. AMF may set calves up for better feed efficiencies and possibly favorable immune 
function and health.  
To ascertain if AMF is efficacious at improving growth and health in preweaned calves, a 
study must be done with AMF included in calf milk replacer and calf starter. Calves must be 
weighed weekly to answer questions about weight gain. Calf health must be monitored in order 
to detect improvement in immune function. Lastly, flow cytometry must be performed on 
intestinal lymph nodes to examine CD4 and CD8 cell populations in order to detect differences 
in T cell population as a measure of immune function. The study outlined below aimed to do all 
of these things. 
It was hypothesized that calves fed 2 g of AMF daily, delivered in calf milk replacer for 
the first 4 wk of life and top-dressed on starter thereafter, will have lower fecal scores and 
treatment costs. Further, it was hypothesized that CD4 and CD8 cell populations of intestinal 
lymph nodes will differ between treatments. 
MATERIALS AND METHODS 
Calves, Diets, and Management:  
The Ohio State University Animal Care and Use Committee approved all animal 
procedures (protocol # 2013A00000059). In this 8 wk trial, 52 locally sourced (Wayne County, 
OH) Holstein bull calves were transported to the OARDC Small Ruminant Research Center 
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(Wooster, OH) on May 6
th
, 2013. Calves were blocked by source farm (n = 14), age (0 to 6 d of 
age), initial body weight, initial IgG score (moderate or high), and lactation number of dam 
(primiparous or multiparous) and randomly assigned to a slaughter age (4 wk (n = 16) or 8 wk (n 
= 36)), and treatment (control (CON; n = 27) or Amaferm (AMF; n = 25)). 
Calves were individually housed in a naturally ventilated barn; the experimental unit was 
calf. Pens had no bedding. Calves were fed non-medicated milk replacer (MR; 22% CP, 20% fat, 
DM basis) from buckets twice daily at 0600 and 1800h. Calves were offered 0.68 kg of MR 
powder mixed in 3.78 L of water per day; MR was delivered in 2 equal portions. Calves assigned 
to AMF received 2g/d of liquid AMF product, delivered in equal portions of MR for the first 4 
wk of the trial. Calves had freechoice access to a medicated (0.0033% Decoquinate) 20% CP 
(DM basis) calf starter and water at all times. For the final 4 wk of the trial, AMF was top-
dressed on calf starter (2 g/d; offered at 0600h feeding). Calves began the 5-d weaning process 
when they consumed 0.91kg of starter for 3 consecutive days or on day 45 of the trial, whichever 
came first. During the weaning process, MR amount was reduced by 50% and was offered at the 
0600h feeding only. Calves were not dehorned or castrated. Calf starter and MR intake were 
measured daily.  
Growth and Health Monitoring 
 Calves were weighed weekly. All vaccination procedures and veterinary care were 
provided by the attending OARDC veterinarian. Upon arrival all calves received 1 mL/nostril 
Inforce-3 (Zoetis, Florham Park, NJ) and 2 mL Excenel (Zoetis) subcutaneously. On d 5 all 
calves received 2 mL Ultrachoice 7 (Zoetis) subcutaneously. Calves received 2 mL preventative 
Excenel subcutaneously on days 4, 6, 7 and 8. In addition, 1 mL per nostril Inforce 3 was 
administered on d 8. Calves being slaughtered at 8 wk received 2 mL Ultrachoice 7 
subcutaneously at d 24. This was not administered to 4 wk calves due to withdrawal time. Calves 
did not receive injections of selenium and vitamins A, D, and E due to the 60 d withdrawal 
period of these injections. 
A 4-point scale was used for twice daily fecal scoring (Diaz et al., 2001). Any calf with a 
fecal score of 3 or greater was offered 1.89 L oral electrolytes (Land O’ Lakes Inc., Shoreview, 
MN). Prevail (Vetone, MWI Veterinary Supply, Boise, ID) was used to treat fever (rectal 
temperature  39.4 ˚C) and discomfort. Infections were treated under the instruction of the 
attending OARDC veterinarian primarily with injectables: Excenel, Draxxin (Zoetis), Nuflor 
(Merck Animal Health, Summit, NJ), or Sustain III calf boluses (Bimeda Inc., Oakbrook 
Terrace, IL). When determining treatment for a symptomatic calf, care was taken to select a 
regimen that did not violate pre-slaughter withdrawal periods. All treatments were recorded for 
calculation of treatment costs (Table 1). 
Table 1. Cost per mL of medications (MWI Veterinary Supply, Boise, ID). 
Drug Cost/mL 
Inforce-3 $ 0.55 
Ultrachoice 7 $ 0.26 
Excenel $ 0.73 
Prevail $ 0.10 
Draxxin $ 3.90 
Nuflor $ 0.62 
Sustain III $ 0.79 
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Sample Collection and Flow Cytometric Analysis 
For slaughter, animals were transported approximately 90 miles to the meat science 
laboratory at The Ohio State University. Feed was not withheld prior to slaughter. Calves were 
slaughtered by captive-bolt stunning followed by exsanguination. Intestinal lymph nodes (~1 
g/calf) were collected from the mesentery surrounding the jejunum and transported back to 
Wooster stored at 4˚C in RPMI (Sigma-Aldrich, St. Louis, MO). 
Each lymph node sample was pressed through a 40 µm cell strainer. The effluent was 
added to 15 mL ice cold RPMI. The lymph cells were centrifuged at 1800 rpm for 5 min at 10˚C. 
Cells were washed once with RPMI and resuspended using running buffer (5 mL 10x PBS, 200 
µL 0.5 M EDTA, 1.5 mL normal goat serum, 43.3 mL autoclaved H2O). The cells were stained 
with FITC-conjugated mouse anti-bovine CD8 monoclonal antibodies (AbD Serotec, Raleigh, 
NC) and RPE-conjugated mouse anti-bovine CD4 monoclonal antibodies (AbD Serotec). Cells 
were incubated for 15 min at 4˚C. After washing thrice, cells were resuspended in running buffer 
and analyzed on a flow cytometer (EMD Millipore Corp, Billenia, MA). 
Data Analysis 
 Data were analyzed using the Proc Mixed Procedure of SAS (version 9.2; SAS Institute; 
Cary, NC). Calf within treatment was the random term. Fixed effects in the model included 
treatment, kill date, and their interaction. The Proc Frequency Procedure of SAS was used to 
generate frequency distribution of categorical data (fecal score and respiratory treatments). Data 
were declared significant when P ≤ 0.05. 
RESULTS 
 Body weight of 8wk slaughter calves throughout the study was not affected by treatment 
(data not shown; P=0.832). On a weekly basis, calves fed AMF exhibited scours (fecal score >2) 
more frequently than CON calves (Figure 1; P=0.01). Scours were more frequent in all calves, 
regardless of treatment, in the early weeks of the trial (Figure 1; P=0.01). Treatment for 
respiratory ailments were more frequent in CON calves than in calves fed AMF (Figure 2; 
P=0.01). 
Figure 1. Percentage of calves scouring over time. Figure 2. Percentage of calves treated for 
respiratory ailments. 
The average total treatment cost per calf (Table 2) includes the cost of all vaccinations, 
medications and electrolytes. Treatment costs were not different between calves on AMF or 
CON in either wk 1-4 or wk 5-8 (P=0.594 and 0.306, respectively). 
Table 2. Average total treatment cost per calf 
 
wk 1-4  
(n=52) 
wk 5-8  
(n=36) 
CON  $    42.79 +/- $2.33   $       9.46 +/- $2.33 
AMF  $    43.24 +/- $ 2.47   $    12.90 +/- $2.47 
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The CD4 cell population of intestinal lymph nodes as a percentage of total observed cells 
was greater in AMF calves (Table 3; P=0.050). Treatment did not affect CD8 cell population as 
a percentage of total observed cells (Table 3; P=0.427). 
Table 3. CD4 and CD8 as a Percentage of Observed Cell Population 
 
CD4 CD8 
CON 24.44 ± 1.65% 5.49 ± 0.61% 
AMF 29.78 ± 1.74% 7.45 ± 0.85% 
DISCUSSION 
Scours and respiratory disease are the two greatest causes of calf morbidity and mortality 
in the US (USDA NAHMS 2011). Two calves on the AMF treatment died due to scours related 
causes. Data from these animals are not reported and these animals were not replaced. In 2010, 
the national mortality rate of preweaned heifers on heifer raising operations was 4.2% (USDA 
NAHMS 2011). The mortality rate for this trial was 3.7%, which is below the national average. 
16.4 % of heifers on heifer raising operations are treated for pneumonia (USDA NAHMS 2011), 
while 50% of calves on this trial were treated for unspecified respiratory ailments. No calves in 
this trial were treated with antibiotics because of scours, while the national average for antibiotic 
scours treatment is 18.2 % (USDA NAHMS 2011). 
It is common for calves to scour within the first 4 wk of life (USDA NAHMS 2011), and 
this was observed in this study. We originally hypothesized that AMF would lower fecal scores. 
This is not what we found. However, a lesser percentage of AMF calves were treated for 
respiratory ailments. This was unexpected, given that AMF is a direct fed microbial and reasons 
behind this difference should be explored in future studies. Given that AMF calves were treated 
more for scours but less for respiratory, the overall treatment cost did not differ between 
treatment, though the cost for AMF calves was numerically higher in both the wk 1-4 and wk 5-8 
periods. 
CD4 cell percentages were higher in AMF calves than in CON calves. This leads us to 
hypothesize that calves fed AMF would be more prepared to fight infection and therefore 
healthier. Future analyses in our lab from these calves will evaluate relative abundance of pro- 
versus anti-inflammatory cytokines in order to reveal whether the CD4 cells present were 
actively fighting an infection (increased pro-inflammatory) or merely regulatory (increased anti-
inflammatory). It should be noted that cell populations could only be recorded at the time of 
slaughter, which does not indicate health status over time. Further analysis is necessary to 
determine the implications and reasons for these higher CD4 populations. While differences in 
CD4 populations were observed in 8 wk old calves due to treatment, CD8 cell populations were 
unaffected. CD8 is more associated with innate immunity than adaptive immunity. Taking 
together our results on CD4 and CD8 cell populations indicate that AMF may affect the adaptive 
immune system through effects mediated by CD4 positive cells. More research is needed in this 
area. 
In conclusion, calves fed AMF scoured more frequently, but a lesser percentage of AMF 
calves were treated for respiratory ailments leading to no effect on treatment costs. Interestingly, 
the CD4 cell population was greater in AMF calves, which warrants further research.  
 
 
 
 
 
5 
 
REFERENCES 
 
Beharka, A. A. and T. G. Nagaraja.  1998.  Effect of Aspergillus oryzae extract alone or in 
combination with antimicrobial compounds on ruminal bacteria.  J. Dairy Sci. 81:1591-1598. 
 
Beharka, A., T. G. Nagaraja, and J. L. Morrill. 1991. Performance and ruminal function 
development of young calves fed diets with Aspergillus oryzae fermentation extract. J. Dairy Sci. 
74:4326-4336. 
Chang, J. S., E. M. Harper, and R. E. Calza.  1999.  Fermentation extract effects on the 
morphology and metabolism of the rumen fungus Neocallimastix frontalis EB188.  J. Appl. 
Microbiol. 86:389-398. 
Diaz, M. C., M. E. Van Amburgh, J. M. Smith, J. M. Kelsey, and E. L. Hutten. 2001. 
Composition of growth of Holstein calves fed milk replacer from birth to 105-kilogram body 
weight. J. Dairy Sci. 84:830-842. 
Davis, C. L. and J. K. Drackley. 1998. The development, nutrition, and management of the 
young calf. Iowa State University Press. Ames, IA. 
Magalhaes, V. J. A., F. Susca, F. S. Lima, A. F. Branco, I. Yoon, and J. E. P. Santos. 2008. 
Effect of Feeding Yeast Culture on Performance, Health, and Immunocompetence of Dairy 
Calves. J. Dairy Sci. 91:1497–1509. 
 
Scibilia, L. S., L. D. Muller, R. S. Kensinger, T. F. Sweeney, and P. R. Shellenberger. 1987. 
Effect of environmental temperature and dietary fat on growth and physiological responses of 
newborn calves. J. Dairy Sci. 70:1426-1433. 
 
Taras, D., W. Vahjen, M. Macha and O. Simon. 2006. Performance, diarrhea incidence, and 
occurrence of Escherichia coli virulence genes during long-term administration of a probiotic 
Enterococcus faecium strain to sows and piglets. J. Animal Sci. 84:608-617. 
 
USDA NAHMS (United States Department of Agriculture, Animal and Plant Health Inspection 
Service). 2012. Dairy Heifer Raiser 2011, An overview of operations that specialize in raising 
dairy heifers. No. 613.1012. USDA: Animal and Plant Health Inspection Service: Veterinary 
Services, Centers for Epidemiology and Animal Health (USDA:APHIS:VS, CEAH), Fort 
Collins, CO 
 
Zimbelman, R. B., and R. J. Collier. 2011. Feeding strategies for high-producing dairy cows 
during periods of elevated heat and humidity. Pages 111-126 in Proc. 2011 Tri-State Dairy 
Nutrition Conf. The Ohio State University, Columbus. 
 
 
